These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 15853949)

  • 1. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of CC16 in nasal fluid of children with birch pollen-induced rhinitis.
    Johansson S; Keen C; Ståhl A; Wennergren G; Benson M
    Allergy; 2005 May; 60(5):638-42. PubMed ID: 15813809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Humoral mucosal immunity in allergic rhinitis].
    Kramer MF; Jordan TR; Pfrogner E; Rasp G
    Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-reactive antibodies are found in nasal fluids from patients with birch pollen-induced intermittent allergic rhinitis, but not in healthy controls.
    Benson M; Reinholdt J; Cardell LO
    Allergy; 2003 May; 58(5):386-92. PubMed ID: 12752324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No decrease of birch pollen specific IgA and IgG in nasal fluids from cortisone treated patients with intermittent allergic rhinitis.
    Benson M; Reinholdt J; Cardell LO
    Allergy; 2004 Mar; 59(3):365-7. PubMed ID: 14982528
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide.
    Bergmann-Hug K; Wirth R; Henseler M; Helbling A; Pichler WJ; Schnyder B
    Allergy; 2009 Nov; 64(11):1629-34. PubMed ID: 19627276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S; Heinrich C; Scheynius A
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis.
    van Hage-Hamsten M; Johansson E; Roquet A; Peterson C; Andersson M; Greiff L; Vrtala S; Valenta R; Grönneberg R
    Clin Exp Allergy; 2002 Oct; 32(10):1448-53. PubMed ID: 12372124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and seasonal exposure to birch pollen in allergic rhinitis and allergic asthma with regard to the inflammatory response.
    Kämpe M; Janson C; Stålenheim G; Stolt I; Carlson M
    Clin Respir J; 2010 Jan; 4(1):37-44. PubMed ID: 20298416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis.
    Schäper C; Gustavus B; Koch B; Ewert R; Hanf G; Kunkel G; Noga O; Gläser S
    J Investig Allergol Clin Immunol; 2009; 19(6):459-64. PubMed ID: 20128420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response.
    Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M
    Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
    J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.
    Meyer P; Andersson M; Persson CG; Greiff L
    Pediatr Allergy Immunol; 2003 Feb; 14(1):60-5. PubMed ID: 12603713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
    Greiff L; Persson CG; Andersson M
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular composition and biological activity of commercial birch pollen allergen extracts.
    Focke M; Marth K; Valenta R
    Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.